About Us
Arrivent was founded in 2021 with a mission to globally develop top biopharma innovations from around the world to deliver important medicines to patients.
Recognizing the plethora of potential first- and best-in-class candidates out of China and other geographic areas such as Europe, South Korea and Japan—and the risk that these might never make it to market due to development challenges in the areas in which they were discovered—we have made it our mission to ensure these innovations get into the hands of patients and physicians across the globe.